India Women’s Health Devices Market Size, Share & COVID-19 Impact Analysis, By Application (Contraceptive Devices, Menstruation Care, Pregnancy & Nursing Care, and Others), By Distribution Channel (Hospitals & Clinics, Home Healthcare, and Others), and Forecast, 2022-2029

The India women’s health devices market size was valued at USD 95.1 million in 2021. The market is projected to grow from USD 102.5 million in 2022 to USD 145.8 million by 2029, exhibiting a CAGR of 5.2% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with women’s health devices experiencing lower-than-anticipated demand across India compared to pre-pandemic levels. Based on our analysis, this market exhibited a decline of -1.3% in 2020 as compared to 2019. 

Women’s health devices are products used for maternal and menstrual care, fertility, and family planning. These products include breast pumps in maternal care, menstrual pain relief devices for dysmenorrhea, pregnancy testing kits, and Intrauterine Devices (IUDs) for fertility and family planning.

The increasing women's health issues and raising awareness among the population regarding the same have been responsible for the increasing adoption of women’s health devices. For instance, rising awareness regarding safer contraceptive methods, such as IUDs, has been boosting the use of these contraceptives to prevent unintended pregnancies in India. Moreover, the women’s health devices market growth is also attributed to increasing government initiatives regarding maternal health, diseases such as AIDS, dysmenorrhea, and other disorders related to menstrual health.

• For instance, the Ministry of Health & Family Welfare (MoHFW) launched the Pradhan Mantri Surakshit Matritva Abhiyan. The government provides free antenatal services and required treatment to pregnant women within 3-6 months of pregnancy through this initiative. This initiative is for women living in under-served, semi-urban, poor, and rural areas.

COVID-19 IMPACT

COVID-19 had a Negative Impact on the Market Growth due to Lockdown Restrictions  

The outbreak of COVID-19 declined the demand for women’s health devices in India. Key players in the market experienced a decline in their revenues due to the COVID-19 pandemic. Female contraceptive products, such as female condoms, intrauterine devices, menstrual pain relief devices, and ovulation monitors, observed a decline in their demand during the COVID-19 pandemic. Strict social distancing norms reduced socializing among people and restrictions on mobility among consumers were responsible for the drop in sales of female contraceptive devices.

• For instance, according to a recent report by the Condom Alliance, condom sales in India dipped 48% in the three-month lockdown period in 2020 as compared to the same period in 2019.

Moreover, due to the supply chain disruptions in the country, menstrual pain relief devices and ovulation monitors observed a significant decline in their demand resulting in a decline in the overall market.  

However, pregnancy and nursing care products witnessed an increase in demand after the outbreak of COVID-19. During lockdown restrictions, pregnancy test kits manufacturers observed a sudden rise in product sales.

• For instance, according to an article published by Afaqs, in 2020, Mankind Pharma’s Prega News experienced a significant increase of 20% in its demand during the lockdown months.

The market experienced significant growth in 2021 and is estimated to completely recover by the end of 2022 due to significant increase in the demand for pregnancy testing kits, contraceptive devices, and other devices.

LATEST TRENDS

Request a Free sample to learn more about this report.

Shift from Therapeutics to Pain Relief Devices for the Treatment of Dysmenorrhea to Boost the Market

Dysmenorrhea is a gynecological condition in which women experience painful menstrual cramps during their menstrual cycle, and nowadays, it has become very common.

• For instance, as per an article published by Women’s Health Concern in 2020, around 80% of women experience period pain at some stage in their lifetime. Women can experience periods of cramps anytime from their early teens to their menopause. Many women experience cramps during menstruation, especially during the first day. However, the pain is very severe in 5% to 10% of women.

Drugs, such as diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen, are available in the market, which give temporary relief from the cramps. These medicines work by decreasing menstrual pain and intrauterine pressure. Moreover, it lowers the prostaglandin F2α (PGF2α) levels in menstrual fluid. Despite the temporary relief offered by these medicines, there are certain side effects associated with these medicines such as indigestion, nausea, vomiting, and headache. This has been restricting women from taking these medicines.

In such a scenario, introduction of women’s health devices providing relief from menstrual cramps, such as Livia, has come out to be very effective for women suffering from menstrual cramps. These devices work by tuning with the menstrual pain’s wavelength frequency and further blocking the menstrual pain. Such safe devices with no side effects are expected to drive the India women’s health devices market in the coming years.

DRIVING FACTORS

Increasing Adoption of Various Pregnancy and Nursing Care Products to Drive the Market

In India, women delivering their first child at a young age after marriage is quite common. On average, women in India generally give birth to their first child at the age of 21 years. Moreover, unplanned pregnancies are also very common among Indian couples.

• For instance, according to the article published by BMC Pregnancy and Childbirth, in 2020, around 85.0 million women experienced unplanned pregnancies globally each year. As per the same data, India accounted for more than one in every seven of these cases. Such high rates of unintended pregnancies are expected to increase demand for pregnancy detection kits, thereby spurring the overall market growth.

Moreover, there are certain government regulatory bodies that work toward promoting women’s health and safety. In India, the Indian Ministry of Health and Family Welfare (MoHFW) supports the use of pregnancy tests in family planning services. The government has increased the accessibility of pregnancy test kits by making them widely available in public clinics for free and in the private sector at a range of prices.

Furthermore, the market players are also focusing on increasing awareness regarding the adoption of pregnancy kits by launching campaigns to increase the adoption of pregnancy test kits in the rural population.

Furthermore, demand for nursing care devices such as breast pumps has also been increasing in the country. Factors such as low milk production by the biological mother, insufficient glandular tissue among some women, rising incidence of infectious diseases among women, and an increasing number of working women in India are expected to support the India women’s health devices market growth in the long run.

Awareness of Safer Contraceptive Methods Such as IUDs in India to Fuel the Market Growth

Contraceptive devices for women are very less common among the population in India. This is due to the lack of knowledge regarding these contraceptive devices and the limited availability of these women’s health devices in the market.

IUDs are 99.0% effective in preventing pregnancy, have a long replacement rate of 5 to 10 years, and provide safety during breastfeeding. The increasing number of unintended pregnancies in India is expected to increase the adoption of intrauterine devices in the upcoming years.

Moreover, the Government of India has been focusing on raising awareness regarding the use of safe contraceptive devices to meet the challenging needs of women in India.

• For instance, as a part of the Family Planning 2020 initiative, the Government of India has promoted the expansion of access to and uptake of IUDs during both the postpartum (PPIUD) periods and interval (IIUD).


• Moreover, the Government of India also initiated Mission Parivar Vikas, a central family planning initiative. The major objective of the initiative is to improve access to contraceptives through the delivery of assured services, ensuring commodity security, and enhancing access to high-quality family planning services. Such initiatives by the government are expected to increase the adoption of intrauterine devices in India.

The advantages associated with the IUDs and their high efficacy have been increasing their adoption among the Indian women population.

• According to a survey published by the National Center for Biotechnology Information (NCBI) in June 2021, in the Gujarat and Rajasthan regions of India, the overall satisfaction with IUD services was extremely high in the woman population.


• Moreover, according to the survey conducted by the Ministry of Health and Family Welfare (MoHFW) from April 2019 to June 2020, the state of Gujarat recorded the highest number of IUD insertions, with over 169 insertions per 10,000 couples.

Such high adoption of intrauterine devices among Indian states and the rising focus of the government to overcome the misconceptions about the side effects of IUDs are expected to contribute to the market growth in the long run.

RESTRAINING FACTORS

Large Women Population Opting for Female Sterilization Method to Hinder the Market

Female sterilization is done to prevent pregnancy permanently, and the process involves blocking the fallopian tubes. Recently female sterilization rates have increased in India.

• For instance, according to the phase-1 data of the National Family Health Survey-5 released in December 2020, 14 out of the 20 states and Union Territories reported increasing female sterilizations. Rural states of Andhra Pradesh were reported to have the highest number of female sterilizations. As per this data, 7 out of 10 married women aged 15 to 49 in rural Andhra Pradesh have been sterilized.


• Moreover, the state-wise data showed that the southern states of Andhra Pradesh had 70.0% female sterilization in rural areas, Telangana observed 62.2%, whereas Karnataka and Kerala observed 59.9% and 494 %, respectively. Almost all the states showed high women sterilization rates in 2019-2020.

The increase in the number of female sterilizations has a direct negative impact on the sale of women's healthcare devices such as intrauterine devices and female condoms.

The adoption of female contraceptive devices such as female condoms and intrauterine devices is already low in India. However, the increasing preference of women for female sterilization is expected to impact the market negatively during the forecast period.

• For instance, as per the recent article published by the Indian Express in 2021, the sales figure of Cupid Ltd., India’s first manufacturer of female condoms, was around 25,000 pieces per annum.

Such an increasing number of women going for female sterilization and the unavailability of contraceptive devices in the Indian market are expected to hinder the market in the coming years.

SEGMENTATION

By Application Analysis

To know how our report can help streamline your business, Speak to Analyst

Rising Number of Unplanned & Unintended Pregnancies to Boost the Demand for Pregnancy & Nursing Care Segment

Based on application, the India women’s health devices market is segmented into contraceptive devices, menstrual care, pregnancy & nursing care, and others.

The pregnancy & nursing care segment held a major revenue share in 2021 and is estimated to hold a significant market share throughout the forecast period.  The growth of the segment is attributed to the benefits of early detection of pregnancy such as prevention of irradiation & teratogens. Early detection of pregnancy also prevents the need for any medications. Furthermore, the increasing number of unintended pregnancies in India has also been increasing the demand for pregnancy & nursing care products.

• For instance, as per the article published by BMC Pregnancy and Childbirth, in 2020, India accounted for more than one in every seven worldwide cases of unplanned pregnancies. Such a large number of unintended pregnancies in India is expected to drive the segmental growth during the forecast period. Moreover, the improvement in healthcare infrastructure has also been boosting the use of pregnancy and nursing care in hospitals.

Furthermore, contraceptive devices accounted for a significant share in 2021 and the segment is expected to grow at a significant CAGR during the forecast period. The high growth rate of the segment during the forecast period is attributed to the increasing awareness related to women's contraceptive methods such as female condoms and intrauterine devices. Moreover, the high adoption of IUDs among users from different Indian states is expected to drive the segmental growth during the forecast period.

• For instance, according to the survey conducted by the Ministry of Health and Family Welfare (MoHFW), for the time period between April 2019 to June 2020, Gujarat, Haryana, and Rajasthan had the highest number of IUD insertions, with over 169, 148, and 142 per 10,000 couples, respectively.

Moreover, the menstruation care segment is expected to grow at a substantial CAGR during the forecast period due to the shift of consumer preference from medicines for menstrual pain relief to menstrual pain relief devices.

KEY INDUSTRY PLAYERS

Market Players with Strong Focus on New Product Launches in Women’s Health Devices Portfolio to Hold Key Market Share

Mankind Pharma and Piramal Enterprises Ltd. are the prominent players in the market and accounted for a significant share in 2021.

Mankind Pharma dominated the market in 2021. The dominance of Mankind Pharma is attributed to the strong performance of its Prega News (pregnancy testing kit) and the company’s increasing focus on increasing the accessibility of its products among the rural population.

• For instance, according to an article published by Forbes India, in November 2021, Mankind Pharma announced its plans to increase the penetration of Prega News to 26.0% from 16.0% by 2026 in the rural population. To accomplish this plan, the company is focusing on partnerships with regional influencers to engage with the rural audience. Such initiatives are expected to increase the demand for pregnancy detection kits during the forecast period.   

Other significant players, including SMB Corporation of India, CooperSurgical Inc. (The Cooper Companies, Inc.), and Cupid Limited are increasing their focus on the adoption of strategies, including new product launches and improvement in distribution network across India to strengthen their market shares.

LIST OF KEY COMPANIES PROFILED:

• CooperSurgical Inc. (The Cooper Companies, Inc.) (U.S.)


• Cupid Limited (India)


• Koninklijke Philips N.V. (Netherlands)


• Cipla Inc. (India)


• SMB Corporation of India (India)


• Mankind Pharma (India)


• Piramal Enterprises Ltd. (India)

KEY INDUSTRY DEVELOPMENTS:

• May 2022 – Mankind Pharma’s Prega News released a new campaign titled ‘SheIsImperfectlyPerfect.’ This campaign was launched with the aim of normalizing a realistic version of motherhood in India.


• April 2022 – Mankind Pharma announced that it is planning to launch a mega IPO (Initial Public Offerings) 2022.


• August 2021 – Koninklijke Philips N.V. planned to invest USD 40.6 million to hire 1,500 people in India in the next 1-2 years. This investment would help the company expand its units in the country, thereby strengthening its presence in India.


• November 2020 – SMB Corporation of India received a manufacturing license from the Government of India to manufacture and sell various products such as IUDs in the domestic market.


• October 2020 – Cipla Inc. (through its subsidiary Cipla Health) partnered with VMLY&R India, a global brand experience agency. This strategic move helped the company to launch its Mamaxpert brand online.

REPORT COVERAGE

An Infographic Representation of India Women’s Health Devices Market

View Full Infographic

To get information on various segments, share your queries with us

The market research report provides a detailed competitive landscape. It focuses on key points such as new product launches in the market. Additionally, it includes the key industry developments such as partnerships, mergers, and acquisitions. Furthermore, the report covers a regional analysis of different segments, company profiles of key market players, and the impact of COVID-19 on the market. The report consists of qualitative and quantitative insights that contribute to the market's growth.

Report Scope & Segmentation